CCM
Consonance Capital Management Portfolio holdings
AUM
$7.28M
This Quarter Return
+124.13%
1 Year Return
-42.86%
3 Year Return
+319.33%
5 Year Return
+899.35%
10 Year Return
–
AUM
$1.64B
AUM Growth
+$1.64B
(+62%)
Cap. Flow
+$226M
Cap. Flow
% of AUM
13.82%
Top 10 Holdings %
Top 10 Hldgs %
56.65%
Holding
43
New
13
Increased
12
Reduced
8
Closed
8
Top Buys
| 1 |
Aurinia Pharmaceuticals
AUPH
|
$82.3M |
| 2 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$67.1M |
| 3 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
$63.2M |
| 4 |
ARQL
Arqule Inc
ARQL
|
$54M |
| 5 |
Exact Sciences
EXAS
|
$53.6M |
Top Sells
| 1 |
AMRN
Amarin Corp
AMRN
|
$96.9M |
| 2 |
Catalyst Pharmaceutical
CPRX
|
$94.9M |
| 3 |
Globus Medical
GMED
|
$67.1M |
| 4 |
Vericel Corp
VCEL
|
$36.3M |
| 5 |
uniQure
QURE
|
$35.8M |
Sector Composition
| 1 | Healthcare | 93.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Insulet
PODD
$23.9B
| $26.7M | 1.63% | 155,800 | – | – |
|
27
ADMA Biologics
ADMA
$4.12B
| $20.7M | 1.26% | 5,166,961 +51,975 | +1% | +$208K |
|
28
STAAR Surgical
STAA
$1.36B
| $15M | 0.91% | 425,800 -801,971 | -65% | -$28.2M |
|
29
Ovid Therapeutics
OVID
$91M
| $12M | 0.73% | +2,888,888 | New | +$12M |
|
30
Krystal Biotech
KRYS
$4.27B
| $11.3M | 0.69% | 203,788 -20,302 | -9% | -$1.12M |
|
|
BEAT
31
DELISTED
BioTelemetry, Inc.
BEAT
| $7.18M | 0.44% | +155,000 | New | +$7.18M |
|
32
Amicus Therapeutics
FOLD
$2.34B
| $4.95M | 0.3% | +507,739 | New | +$4.95M |
|
|
TPTX
33
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $4.44M | 0.27% | +71,300 | New | +$4.44M |
|
34
Apellis Pharmaceuticals
APLS
$3.48B
| $4.13M | 0.25% | +135,000 | New | +$4.13M |
|
|
MOR
35
DELISTED
MorphoSys AG American Depositary Shares
MOR
| $769K | 0.05% | +21,561 | New | +$769K |
|
|
AMRN
36
Amarin Corp
AMRN
$311M
| – | – | -6,390,259 | Closed | -$96.9M |
|
37
ANI Pharmaceuticals
ANIP
$2.03B
| – | – | -142,943 | Closed | -$10.4M |
|
|
38
Catalyst Pharmaceutical
CPRX
$2.52B
| – | – | -17,875,655 | Closed | -$94.9M |
|
|
39
Globus Medical
GMED
$8.27B
| – | – | -1,313,177 | Closed | -$67.1M |
|
40
Mustang Bio
MBIO
$10.9M
| – | – | -3,160,000 | Closed | -$10.3M |
|
41
Savara
SVRA
$567M
| – | – | -1,568,002 | Closed | -$4.16M |
|
42
Q32 Bio
QTTB
$20.9M
| – | – | -40,557 | Closed | -$734K |
|
|
IMMU
43
DELISTED
Immunomedics Inc
IMMU
| – | – | -45,000 | Closed | -$597K |
|